Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2015 Nov;21(11):2045-7.
doi: 10.3201/eid2111.150750.

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA

Fosfomycin Resistance in Escherichia coli, Pennsylvania, USA

Hind Alrowais et al. Emerg Infect Dis. 2015 Nov.

Abstract

Fosfomycin resistance in Escherichia coli is rare in the United States. An extended-spectrum β-lactamase-producing E. coli clinical strain identified in Pennsylvania, USA, showed high-level fosfomycin resistance caused by the fosA3 gene. The IncFII plasmid carrying this gene had a structure similar to those found in China, where fosfomycin resistance is commonly described.

Keywords: 16S rRNA methyltransferase; ESBL; Escherichia coli; Pennsylvania; United States; antimicrobial resistance; bacteria; extended-spectrum β-lactamase; fosA3 gene; fosfomycin resistance; glutathione S-transferase; plasmids.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Comparative analysis of fosA3-carrying IncFII plasmids pYHCC with pXZ. Open reading frames are indicated by arrows and colored according to their putative functions: magenta arrows indicate genes involved in replication; blue arrows indicate genes associated with plasmid conjugal transfer. Brown arrows indicate genes involved in plasmid stability; red arrows indicate antimicrobial drug resistance genes; green arrows indicate accessory genes of mobile elements; gray arrows indicate other backbone genes and inserted foreign genes. Light blue shading indicates shared backbone regions with a high degree of homology. MRR, multidrug resistance region.
Figure 2
Figure 2
EcoRI restriction profile of fosA3-carrying plasmids from a woman in Pennsylvania, USA, who was colonized with fosfomycin-resistant Escherichia coli. Lanes M, lambda DNA/HindIII marker; lane 1, February 2011 (YD472); lane 2, March 2008; lane 3, June 2007 (ECRB1); lane 4, April 2008; lane 5, January 2008. Values on the left are in kilobases.

References

    1. Johnson JR, Drawz SM, Porter S, Kuskowski MA. Susceptibility to alternative oral antimicrobial agents in relation to sequence type ST131 status and coresistance phenotype among recent Escherichia coli isolates from U.S. veterans. Antimicrob Agents Chemother. 2013;57:4856–60. 10.1128/AAC.00650-13 - DOI - PMC - PubMed
    1. Castañeda-García A, Blázquez J, Rodríguez-Rojas A. Molecular mechanisms and clinical impact of acquired and intrinsic fosfomycin resistance. Antibiotics. 2013;2:217–36. - PMC - PubMed
    1. Wachino J, Yamane K, Suzuki S, Kimura K, Arakawa Y. Prevalence of fosfomycin resistance among CTX-M-producing Escherichia coli clinical isolates in Japan and identification of novel plasmid-mediated fosfomycin-modifying enzymes. Antimicrob Agents Chemother. 2010;54:3061–4. 10.1128/AAC.01834-09 - DOI - PMC - PubMed
    1. Doi Y, Adams-Haduch JM, Paterson DL. Escherichia coli isolate coproducing 16S rRNA nethylase and CTX-M-type extended-spectrum β-lactamase isolated from an outpatient in the United States. Antimicrob Agents Chemother. 2008;52:1204–5. 10.1128/AAC.01320-07 - DOI - PMC - PubMed
    1. Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing; twenty-fourth informational supplement M100–S24. Wayne (PA): The Institute; 2014.

Publication types

MeSH terms

LinkOut - more resources